Mankind Pharma will take over the entire business of Bharat Serums and Vaccines Limited (BSVL) through a voluntary liquidation of the subsidiary rather than a court-sanctioned scheme of arrangement, disclosures reviewed by insolvencytracker.in show — an integration route that sidesteps the NCLT approval process that ordinarily governs group mergers.
BSVL, which Mankind acquired for Rs 13,768 crore in October 2024, commenced voluntary liquidation on 7 September 2026 under Section 59 of the Insolvency and Bankruptcy Code, 2016. The Form A public announcement, issued on 8 September under Regulation 14 of the IBBI (Voluntary Liquidation Process) Regulations, 2017, sets 7 October 2026 as the last date for stakeholders to…